Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / McNeil AB

Clinicaltrial registered23 Oct 2026

McNeil AB

23 Oct 2026: Trial registered · A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
23 Oct 2026
Title
A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers
Conditions
Smoking Cessation, Nicotine Replacements Therapy
Phase
Phase 2
Study Type
Interventional
Status
Recruiting
Countries
Canada
Country
Canada
Reference
NCT07893158
Location
Canada
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at McNeil AB

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Canada

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.